Programa de Biología y Regeneración Oral

Medicine & Life Sciences

1. Gingival Crevicular Fluid 100%
2. Mesenchymal Stem Cells 91%
3. Periodontitis 84%
4. Dental Pulp 72%
5. Tooth 65%
6. Periapical Periodontitis 49%
7. Regenerative Endodontics 46%
8. Pulpitis 41%
9. Gestational Diabetes 41%
10. Biomarkers 38%
11. Extracellular Vesicles 36%
12. Dental Pulp Cavity 35%
13. Stem Cells 32%
14. Pregnancy 32%
15. Peri-Implantitis 31%
16. Matrix Metalloproteinase 8 30%
17. Pre-Eclampsia 29%
18. Endodontics 29%
19. Platelet-Rich Fibrin 28%
20. Neuropilin-1 27%
21. Case-Control Studies 24%
22. tricalcium silicate 20%
23. Cell Proliferation 20%
24. Cone-Beam Computed Tomography 20%
25. Regeneration 20%
26. placental alkaline phosphatase 19%
27. C-Reactive Protein 19%
28. Porphyromonas gingivalis 18%
29. Cross-Sectional Studies 17%
30. Calcium Hydroxide 17%
31. Logistic Models 17%
32. Dentinal Fluid 17%
33. Porphyromonas endodontalis 16%
34. Periodontal Diseases 16%
35. Tissue Engineering 16%
36. Chronic Periodontitis 15%
37. Dentin 15%
38. Rheumatoid Arthritis 15%
39. Porphyromonas 14%
40. Dental Sac 14%
41. Dental Pulp Capping 14%
42. Cell- and Tissue-Based Therapy 14%
43. Treponema denticola 14%
44. Intercellular Signaling Peptides and Proteins 14%
45. Blood Grouping and Crossmatching 13%
46. Dental Papilla 13%
47. Mucositis 13%
48. Acellular Dermis 13%
49. Workflow 13%
50. Toll-Like Receptor 2 13%
51. mineral trioxide aggregate 13%
52. Randomized Controlled Trials 12%
53. ROC Curve 12%
54. Ultrasonic Waves 12%
55. Bicuspid 12%
56. Placenta 12%
57. Tooth Extraction 11%
58. Therapeutics 11%
59. In Vitro Techniques 11%
60. DNA 11%
61. Enzyme-Linked Immunosorbent Assay 11%
62. Human Genetics 11%
63. Phase II Clinical Trials 11%
64. Clinical Trials, Phase I 11%
65. Connective Tissue 11%
66. poly(lactide) 11%
67. Polymers 11%
68. Porosity 10%
69. Interleukin-6 10%
70. Pregnant Women 10%
71. Molecular Pathology 10%
72. Umbilical Cord 10%
73. Pregnancy Complications 10%
74. Angiogenesis Inducing Agents 10%
75. Cell Differentiation 10%
76. Pedigree 10%
77. Blood Platelets 10%
78. Controlled Clinical Trials 10%
79. Matrix Metalloproteinases 10%
80. Early Diagnosis 10%
81. Matrix Metalloproteinase 9 9%
82. Mouth 9%
83. Formaldehyde 9%
84. Maxilla 9%
85. Chile 9%
86. Fetal Development 9%
87. Regulatory T-Lymphocytes 9%
88. Mandible 9%
89. Type 2 Diabetes Mellitus 9%
90. High-Throughput Nucleotide Sequencing 8%
91. Systemic Lupus Erythematosus 8%
92. Chemokines 8%
93. Paraffin 8%
94. Young Adult 8%
95. Methylation 8%
96. Area Under Curve 8%
97. Low-Level Light Therapy 8%
98. Tartrate-Resistant Acid Phosphatase 8%
99. Osteoprotegerin 7%
100. MicroRNAs 7%